Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 2.1 Exhibit 2.1 Share Exchange Agreement, Dated As of March 17, 2020 by and Among AXIM Biotechnologies, Inc., Sapphire Biotech, Inc. and Its Stockholders
- 10.1 Exhibit 10.1 Form of Lock-up Agreement
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits
AXIM similar filings
- 13 May 20 AXIM® Biotechnologies Issues Update Letter to Shareholders
- 12 May 20 Entry into a Material Definitive Agreement
- 27 Mar 20 Other Events
- 18 Mar 20 Entry into a Material Definitive Agreement
- 8 Jan 20 Entry into a Material Definitive Agreement
- 17 Dec 19 Entry into a Material Definitive Agreement
- 9 Jul 19 Axim® Biotechnologies Signs Licensing Agreement with Leading Gum Distributor to Expand Nutraceutical Division
Filing view
External links
